May 30, 2014 — Alere announced a class I recall of its INRatio2 PT/INR professional test strips, part of the Alere ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
May 22, 2014 — Hospira Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 ...
May 22, 2014
May 14, 2014 — The National Lipid Assn. (NLA) released a draft summary that highlights key aspects of care that provide ...
May 14, 2014May 12, 2014 — New data presented for the first time at the World Heart Federation’s World Congress of Cardiology 2014 ...
May 12, 2014May 6, 2014 — The National Lipid Association (NLA) recently convened an expert panel to examine various aspects of ...
May 06, 2014April 29, 2014 — Armetheon Inc. announced it has reached agreement with the U.S. Food and Drug Administration (FDA) on a ...
April 29, 2014April 21, 2014 — Decision Resources Group announced in a report that Servier's ivabradine (procoralan) is set to become ...
April 21, 2014
April 10, 2014 — The 2014 Guideline for the Management of Patients With Atrial Fibrillation includes recommendations for ...
April 10, 2014April 9, 2014 — LipoScience Inc. announced data showing that patients managed to a target LDL particle (LDL-P) number ...
April 09, 2014
April 7, 2014 — In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major ...
April 07, 2014
April 7, 2014 — Strategies aimed at reducing the number of patients with heart failure and other cardiovascular ...
April 07, 2014April 2, 2014 — Statins are associated with a significant improvement in erectile function, a fact researchers hope will ...
April 02, 2014
March 25, 2014 – As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind ...
March 25, 2014March 25, 2014 — Patient enrollment has been completed four months ahead of plan in the Phase III clinical trial EUCLID ...
March 25, 2014March 12, 2014 — Janssen Research and Development LLC (Janssen) announced the U.S. Food and Drug Administration (FDA) ...
March 12, 2014